Antimicrobial Resistance in Urinary Tract Infections

Purpose of Review This review aims to summarize the recent literature regarding antimicrobial-resistant urinary tract infections in the United States and discuss the impact on the care of urologic patients. We discuss strategies to mitigate the development of antimicrobial resistance and outline bas...

Full description

Saved in:
Bibliographic Details
Published in:Current bladder dysfunction reports 2023-03, Vol.18 (1), p.1-9
Main Authors: Damm, Tiffany L., Cameron, Anne P.
Format: Article
Language:English
Subjects:
Geriatrics/Gerontology
Gynecology
Inflammatory/Infectious Bladder Disorders (MS Mourad
Medicine
Medicine & Public Health
Section Editor
Topical Collection on Inflammatory/Infectious Bladder Disorders
Urology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose of Review This review aims to summarize the recent literature regarding antimicrobial-resistant urinary tract infections in the United States and discuss the impact on the care of urologic patients. We discuss strategies to mitigate the development of antimicrobial resistance and outline basic recommendations for empiric treatment of antimicrobial-resistant urinary tract infections. Recent Findings Several studies have attempted to evaluate the prevalence, risk factors, burden, and implications of antimicrobial-resistant urinary tract infections. Recent guidelines from the Infectious Disease Society of America in 2011 and 2022 provide recommendations for empiric acute uncomplicated cystitis treatment and considerations for empiric treatment of antimicrobial-resistant infections, respectively. Summary Antimicrobial-resistant urinary tract infections are common in urologic patients and increase the risk of adverse effects when not appropriately treated. It is a urologists’ due diligence to prescribe appropriate antimicrobial prophylaxis and treatment and to prevent further development of antimicrobial resistance. Novel non-antimicrobial therapies are promising for treatment and reduction of antimicrobial-resistant infections but require further investigation.
ISSN:1931-7212
1931-7220
DOI:10.1007/s11884-022-00674-3